[a
]CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology,
Chinese Academy of Sciences, Beijing 100101, China
[b
]University of Chinese Academy of Sciences, Beijing 100049, China
[c
]Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science,
Chinese Academy of Sciences, Beijing 100101, China
[d
]CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute
of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
[e
]Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital,
Shenzhen 518112, China
[f
]School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China
[g
]West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy,
West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy,
Chengdu, Sichuan 610041, China
[h
]State Key Laboratory for Emerging Infectious Diseases, The University of Hong Kong,
Pokfulam 999077, Hong Kong Special Administration Region
[i
]Department of Microbiology, The University of Hong Kong, Pokfulam 999077, Hong Kong
Special Administration Region
[j
]Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,
Zhejiang University, Hangzhou 310003, China
[
k
]Center for Influenza Research and Early-warning (CASCIRE), Chinese Academy of Sciences,
Beijing 100101, China
[
l
]National Institute for Viral Disease Control and Prevention, Chinese Center for Disease
Control and Prevention (China CDC), Beijing 102206, China
License:
Since January 2020 Elsevier has created a COVID-19 resource centre with free information
in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre
is hosted on Elsevier Connect, the company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre - including this research content - immediately
available in PubMed Central and other publicly funded repositories, such as the WHO
COVID database with rights for unrestricted research re-use and analyses in any form
or by any means with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre remains active.